Trial intelligence / Profile preview

Effect of mirtazapine on seizure frequency in medically refractory epileptic patients with vagal nerve stimulation

2018-003464-32Phase 4Completed

Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of mirtazapine in Focal Onset Epilepsy. Primary endpoint: Changes in seizure frequency. Started Nov 2019; status: completed.

02

Drugs

mirtazapine
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on 2018-003464-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003464-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call